IMTXW (Immatics NV) 6-1 Month Momentum %: N/A% (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMTXW Immatics NV IMTXW
60 GF Score
Price $0.00
! 4 Warning Signs
View Full Analysis

What is Immatics NV 6-1 Month Momentum %?

Immatics NV IMTXW 60 6-1 Month Momentum % is N/A% as of Sep. 10, 2026. GuruFocus rates IMTXW with a GF Score™ of 60/100. The stock has 4 warning signs investors should review. Among 1,376 Biotechnology companies, Immatics NV ranks better than 60.25% on this metric.

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-09-10), Immatics NV's 6-1 Month Momentum % is N/A%.

The industry rank for Immatics NV's 6-1 Month Momentum % or its related term are showing as below:

IMTXW's 6-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -11.235
* Ranked among companies with meaningful 6-1 Month Momentum % only.

Immatics NV  (NAS:IMTXW) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Immatics NV 6-1 Month Momentum % Related Terms

IMTXW vs AKTS, REPL, CGEM: 6-1 Month Momentum % Comparison

For the Biotechnology subindustry, Immatics NV's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immatics NV 6-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Immatics NV's 6-1 Month Momentum % falls into.


IMTXW
60GF Score
Immatics NV IMTXW
6-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immatics NV  (NAS:IMTXW) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-1 Month Momentum % →
What does a 6-1 Month Momentum % of N/A% mean?
Immatics NV (IMTXW) has a 6-1 Month Momentum % of N/A% as of Sep. 10, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Immatics NV and its competitors. According to the industry distribution chart, Immatics NV ranks #547 out of 1376 companies in the Biotechnology industry, placing it in the top 39.8%.
Is Immatics NV's 6-1 Month Momentum % too high?
Immatics NV's current 6-1 Month Momentum % is N/A%. Based on the distribution chart, Immatics NV ranks #547 out of 1376 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Immatics NV has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Immatics NV's 6-1 Month Momentum % compare to AKTS and REPL?
According to the Biotechnology industry distribution chart, Immatics NV ranks #547 out of 1376 companies for 6-1 Month Momentum %. This puts Immatics NV in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Biotechnology company?
A good 6-1 Month Momentum % depends on the Biotechnology industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Immatics NV and its competitors. Immatics NV's current 6-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immatics NV stock overvalued right now?
Immatics NV (IMTXW) has a current 6-1 Month Momentum % of N/A%. The current 6-1 Month Momentum % is N/A%. Immatics NV's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For Immatics NV (IMTXW), the current 6-1 Month Momentum % is N/A% as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immatics NV Business Description

Other Exchanges IMTX:USA4A3:Germany
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
60GF Score

Get the complete analysis for IMTXW

6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price